Summary

The global market for Veterinary Insulin Syringes was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 559%.

This report aims to provide a comprehensive presentation of the global market for Veterinary Insulin Syringes, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Veterinary Insulin Syringes by region & country, by Type, and by Application.
The Veterinary Insulin Syringes market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Insulin Syringes.

Market Segmentation
By Company
Cardinal Health
B. Braun VetCare
Merck
BD
Covetrus
SOL-Millennium
Trividia Health
Knight Benedikt
UltiMed
CarePoint VET
Pharma Supply
MWI Veterinary Supply
Medtronic
Segment by Type
U-40
U-100
Segment by Application
Companion Animals
Livestock Animals
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Veterinary Insulin Syringes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Veterinary Insulin Syringes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Veterinary Insulin Syringes in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Veterinary Insulin Syringes Product Introduction
1.2 Global Veterinary Insulin Syringes Market Size Forecast
1.2.1 Global Veterinary Insulin Syringes Sales Value (2020-2031)
1.2.2 Global Veterinary Insulin Syringes Sales Volume (2020-2031)
1.2.3 Global Veterinary Insulin Syringes Sales Price (2020-2031)
1.3 Veterinary Insulin Syringes Market Trends & Drivers
1.3.1 Veterinary Insulin Syringes Industry Trends
1.3.2 Veterinary Insulin Syringes Market Drivers & Opportunity
1.3.3 Veterinary Insulin Syringes Market Challenges
1.3.4 Veterinary Insulin Syringes Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Veterinary Insulin Syringes Players Revenue Ranking (2024)
2.2 Global Veterinary Insulin Syringes Revenue by Company (2020-2025)
2.3 Global Veterinary Insulin Syringes Players Sales Volume Ranking (2024)
2.4 Global Veterinary Insulin Syringes Sales Volume by Company Players (2020-2025)
2.5 Global Veterinary Insulin Syringes Average Price by Company (2020-2025)
2.6 Key Manufacturers Veterinary Insulin Syringes Manufacturing Base and Headquarters
2.7 Key Manufacturers Veterinary Insulin Syringes Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Veterinary Insulin Syringes
2.9 Veterinary Insulin Syringes Market Competitive Analysis
2.9.1 Veterinary Insulin Syringes Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Veterinary Insulin Syringes Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Insulin Syringes as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 U-40
3.1.2 U-100
3.2 Global Veterinary Insulin Syringes Sales Value by Type
3.2.1 Global Veterinary Insulin Syringes Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Veterinary Insulin Syringes Sales Value, by Type (2020-2031)
3.2.3 Global Veterinary Insulin Syringes Sales Value, by Type (%) (2020-2031)
3.3 Global Veterinary Insulin Syringes Sales Volume by Type
3.3.1 Global Veterinary Insulin Syringes Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Veterinary Insulin Syringes Sales Volume, by Type (2020-2031)
3.3.3 Global Veterinary Insulin Syringes Sales Volume, by Type (%) (2020-2031)
3.4 Global Veterinary Insulin Syringes Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Companion Animals
4.1.2 Livestock Animals
4.2 Global Veterinary Insulin Syringes Sales Value by Application
4.2.1 Global Veterinary Insulin Syringes Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Veterinary Insulin Syringes Sales Value, by Application (2020-2031)
4.2.3 Global Veterinary Insulin Syringes Sales Value, by Application (%) (2020-2031)
4.3 Global Veterinary Insulin Syringes Sales Volume by Application
4.3.1 Global Veterinary Insulin Syringes Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Veterinary Insulin Syringes Sales Volume, by Application (2020-2031)
4.3.3 Global Veterinary Insulin Syringes Sales Volume, by Application (%) (2020-2031)
4.4 Global Veterinary Insulin Syringes Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Veterinary Insulin Syringes Sales Value by Region
5.1.1 Global Veterinary Insulin Syringes Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Veterinary Insulin Syringes Sales Value by Region (2020-2025)
5.1.3 Global Veterinary Insulin Syringes Sales Value by Region (2026-2031)
5.1.4 Global Veterinary Insulin Syringes Sales Value by Region (%), (2020-2031)
5.2 Global Veterinary Insulin Syringes Sales Volume by Region
5.2.1 Global Veterinary Insulin Syringes Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Veterinary Insulin Syringes Sales Volume by Region (2020-2025)
5.2.3 Global Veterinary Insulin Syringes Sales Volume by Region (2026-2031)
5.2.4 Global Veterinary Insulin Syringes Sales Volume by Region (%), (2020-2031)
5.3 Global Veterinary Insulin Syringes Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Veterinary Insulin Syringes Sales Value, 2020-2031
5.4.2 North America Veterinary Insulin Syringes Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Veterinary Insulin Syringes Sales Value, 2020-2031
5.5.2 Europe Veterinary Insulin Syringes Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Veterinary Insulin Syringes Sales Value, 2020-2031
5.6.2 Asia Pacific Veterinary Insulin Syringes Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Veterinary Insulin Syringes Sales Value, 2020-2031
5.7.2 South America Veterinary Insulin Syringes Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Veterinary Insulin Syringes Sales Value, 2020-2031
5.8.2 Middle East & Africa Veterinary Insulin Syringes Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Veterinary Insulin Syringes Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Veterinary Insulin Syringes Sales Value
6.2.1 Key Countries/Regions Veterinary Insulin Syringes Sales Value, 2020-2031
6.2.2 Key Countries/Regions Veterinary Insulin Syringes Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Veterinary Insulin Syringes Sales Value, 2020-2031
6.3.2 United States Veterinary Insulin Syringes Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Veterinary Insulin Syringes Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Veterinary Insulin Syringes Sales Value, 2020-2031
6.4.2 Europe Veterinary Insulin Syringes Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Veterinary Insulin Syringes Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Veterinary Insulin Syringes Sales Value, 2020-2031
6.5.2 China Veterinary Insulin Syringes Sales Value by Type (%), 2024 VS 2031
6.5.3 China Veterinary Insulin Syringes Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Veterinary Insulin Syringes Sales Value, 2020-2031
6.6.2 Japan Veterinary Insulin Syringes Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Veterinary Insulin Syringes Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Veterinary Insulin Syringes Sales Value, 2020-2031
6.7.2 South Korea Veterinary Insulin Syringes Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Veterinary Insulin Syringes Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Veterinary Insulin Syringes Sales Value, 2020-2031
6.8.2 Southeast Asia Veterinary Insulin Syringes Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Veterinary Insulin Syringes Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Veterinary Insulin Syringes Sales Value, 2020-2031
6.9.2 India Veterinary Insulin Syringes Sales Value by Type (%), 2024 VS 2031
6.9.3 India Veterinary Insulin Syringes Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Cardinal Health
7.1.1 Cardinal Health Company Information
7.1.2 Cardinal Health Introduction and Business Overview
7.1.3 Cardinal Health Veterinary Insulin Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Cardinal Health Veterinary Insulin Syringes Product Offerings
7.1.5 Cardinal Health Recent Development
7.2 B. Braun VetCare
7.2.1 B. Braun VetCare Company Information
7.2.2 B. Braun VetCare Introduction and Business Overview
7.2.3 B. Braun VetCare Veterinary Insulin Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 B. Braun VetCare Veterinary Insulin Syringes Product Offerings
7.2.5 B. Braun VetCare Recent Development
7.3 Merck
7.3.1 Merck Company Information
7.3.2 Merck Introduction and Business Overview
7.3.3 Merck Veterinary Insulin Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Merck Veterinary Insulin Syringes Product Offerings
7.3.5 Merck Recent Development
7.4 BD
7.4.1 BD Company Information
7.4.2 BD Introduction and Business Overview
7.4.3 BD Veterinary Insulin Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 BD Veterinary Insulin Syringes Product Offerings
7.4.5 BD Recent Development
7.5 Covetrus
7.5.1 Covetrus Company Information
7.5.2 Covetrus Introduction and Business Overview
7.5.3 Covetrus Veterinary Insulin Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Covetrus Veterinary Insulin Syringes Product Offerings
7.5.5 Covetrus Recent Development
7.6 SOL-Millennium
7.6.1 SOL-Millennium Company Information
7.6.2 SOL-Millennium Introduction and Business Overview
7.6.3 SOL-Millennium Veterinary Insulin Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 SOL-Millennium Veterinary Insulin Syringes Product Offerings
7.6.5 SOL-Millennium Recent Development
7.7 Trividia Health
7.7.1 Trividia Health Company Information
7.7.2 Trividia Health Introduction and Business Overview
7.7.3 Trividia Health Veterinary Insulin Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Trividia Health Veterinary Insulin Syringes Product Offerings
7.7.5 Trividia Health Recent Development
7.8 Knight Benedikt
7.8.1 Knight Benedikt Company Information
7.8.2 Knight Benedikt Introduction and Business Overview
7.8.3 Knight Benedikt Veterinary Insulin Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Knight Benedikt Veterinary Insulin Syringes Product Offerings
7.8.5 Knight Benedikt Recent Development
7.9 UltiMed
7.9.1 UltiMed Company Information
7.9.2 UltiMed Introduction and Business Overview
7.9.3 UltiMed Veterinary Insulin Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 UltiMed Veterinary Insulin Syringes Product Offerings
7.9.5 UltiMed Recent Development
7.10 CarePoint VET
7.10.1 CarePoint VET Company Information
7.10.2 CarePoint VET Introduction and Business Overview
7.10.3 CarePoint VET Veterinary Insulin Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 CarePoint VET Veterinary Insulin Syringes Product Offerings
7.10.5 CarePoint VET Recent Development
7.11 Pharma Supply
7.11.1 Pharma Supply Company Information
7.11.2 Pharma Supply Introduction and Business Overview
7.11.3 Pharma Supply Veterinary Insulin Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Pharma Supply Veterinary Insulin Syringes Product Offerings
7.11.5 Pharma Supply Recent Development
7.12 MWI Veterinary Supply
7.12.1 MWI Veterinary Supply Company Information
7.12.2 MWI Veterinary Supply Introduction and Business Overview
7.12.3 MWI Veterinary Supply Veterinary Insulin Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 MWI Veterinary Supply Veterinary Insulin Syringes Product Offerings
7.12.5 MWI Veterinary Supply Recent Development
7.13 Medtronic
7.13.1 Medtronic Company Information
7.13.2 Medtronic Introduction and Business Overview
7.13.3 Medtronic Veterinary Insulin Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Medtronic Veterinary Insulin Syringes Product Offerings
7.13.5 Medtronic Recent Development
8 Industry Chain Analysis
8.1 Veterinary Insulin Syringes Industrial Chain
8.2 Veterinary Insulin Syringes Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Veterinary Insulin Syringes Sales Model
8.5.2 Sales Channel
8.5.3 Veterinary Insulin Syringes Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer